News
Sant Joan de Déu coordinates the European project ARI-chALL to promote a new clinical trial in pediatric leukemia
Sant Joan de Déu coordinates the European project ARI-chALL, an international initiative that promotes a new clinical trial with the aim of identifying a treatment for children with acute lymphoblastic leukemia (ALL) in first relapse through the CAR-T ARI-0001 therapy.
Reduced working hours benefit health, but may increase gender differences
According to a study by the Hospital del Mar Research Institute, Pompeu Fabra University and Sant Joan de Deu Research Institute, working fewer hours while maintaining the same salary has a positive effect on physical and mental health and work-life balance.
New scientific review analyzes the connection between immunity and post-COVID cognitive alterations
This publication comprehensively analyzes how SARS-CoV-2 infection can affect cognitive function through immunological mechanisms and alterations of the blood-brain barrier.
New study reveals that one in four patients who start treatment with benzodiazepines uses them for a long time
According to the data analyzed, 27.1% of patients who receive a new prescription for this type of drug end up becoming long-term users after three months, and 14.5% are still so after six months.
Agenda
TECSAM | Dona i innovació: emprenedoria i inversió amb impacte
La Xarxa TECSAM, en col·laboració amb WA4STEAM, organitza una trobada adreçada a persones emprenedores de l'àmbit científic, tecnològic i de la salut interessades a conèixer com preparar projectes innovadors per créixer i accedir a finançament.
Interviews
Susana Ochoa Güerre
Psychologist, head of the Research Group on Etiopathogenesis and Treatment of Severe Mental Disorders (MERITT) at the Institut de Recerca Sant Joan de Déu (IRSJD) and head of research at the Parc Sanitari Sant Joan de Déu (PSSJD).
